Linked Life Data

15653647

Source:http://linkedlifedata.com/resource/pubmed/id/15653647

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
2005-1-17
pubmed:abstractText
Peptide receptor-targeted radionuclide therapy of somatostatin receptor-expressing tumors is a promising application of radiolabeled somatostatin analogs. Suitable radionuclides are (90)Y, a pure, high-energy beta-emitter (2.27 MeV), and (177)Lu, a medium-energy beta-emitter (0.5 MeV) with a low-abundance gamma.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0161-5505
pubmed:author
pubmed:issnType
Print
pubmed:volume
46 Suppl 1
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
13S-7S
pubmed:dateRevised
2006-4-24
pubmed:meshHeading
pubmed:year
2005
pubmed:articleTitle
Combination radionuclide therapy using 177Lu- and 90Y-labeled somatostatin analogs.
pubmed:affiliation
Department of Nuclear Medicine, Erasmus Medical College, Rotterdam, The Netherlands. m.hendricks-dejong@erasmusmc.nl
pubmed:publicationType
Journal Article, Evaluation Studies